Preconditioning Promotes Survival and Angiomyogenic Potential of Mesenchymal Stem Cells in the Infarcted Heart via NF-κB Signaling

被引:76
作者
Afzal, Muhammad R. [1 ]
Haider, Husnain Kh. [1 ]
Idris, Niagara Muhammad [1 ]
Jiang, Shujia [1 ]
Ahmed, Rafeeq P. H. [1 ]
Ashraf, Muhammad [1 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA
关键词
TEMPORAL CONTROL; APOPTOSIS; INHIBITION; ACTIVATION; CANCER;
D O I
10.1089/ars.2009.2755
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
We proposed that pharmacological manipulation of mesenchymal stem cells (MSCs) with diazoxide enhanced their survival and regenerative potential via NF kappa B regulation. MSCs preconditioned ((MSCs)-M-PC) with diazoxide and later subjected to oxidant stress with 100 mu mol/L H2O2 either immediately or after 24 h exhibited higher survival (p < 0.01 vs nonpreconditioned MSCs; Non-PCMSCs) with concomitantly increased phosphorylation of PI3K, Akt, GSK3 beta (cytoplasmic), and NF-kappa B (p65) (nuclear). Akt kinase activity was determined as a function of GSK3 beta activity. Pretreatment of (MSCs)-M-PC with Wortmannin (Wt), NEMO-binding domain (NBD), or NF-kappa B (p50) siRNA abolished v (p65) activity. Preconditioning increased NF-kappa B-dependent elevation of secretable growth factors associated with their paracrine effects. Inhibition of PI3K activity with Wt reduced (MSCs)-M-PC viability at both early and 24 h time-points. However, inhibition of NF-kappa B reduced viability of (MSCs)-M-PC only at 24 h time-point. For in vivo studies, DMEM without cells (group-1) or containing 1 x 10(6) male Non-PCMSCs (group-2), (MSCs)-M-PC (group-3), (MSCs)-M-PC pretreated with Wortmannin (group-4) or NF-kappa B decoy (group-5) were transplanted in a female rat model of acute myocardial infarction. Group-3 showed highest cell survival and growth factor expression, increased angiomyogenesis, and functional improvement. We conclude that activation of NF-kappa B by preconditioning promoted (MSCs)-M-PC survival and angiomyogenic potential in the infarcted heart. Antioxid. Redox Signal. 12, 693-702.
引用
收藏
页码:693 / 702
页数:10
相关论文
共 24 条
[1]
TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling [J].
Becker, C ;
Fantini, MC ;
Schramm, C ;
Lehr, HA ;
Wirtz, S ;
Nikolaev, A ;
Burg, J ;
Strand, S ;
Kiesslich, R ;
Huber, S ;
Ito, H ;
Nishimoto, N ;
Yoshizaki, K ;
Nishimoto, N ;
Galle, PR ;
Blessing, M ;
Rose-John, S ;
Neurath, MF .
IMMUNITY, 2004, 21 (04) :491-501
[2]
Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction [J].
Hahn, Joo-Yong ;
Cho, Hyun-Ju ;
Kang, Hyun-Jae ;
Kim, Tack-Scung ;
Kim, Mi-Hyung ;
Chung, Jung-Hwa ;
Bae, Jang-Whan ;
Oh, Byung-Hee ;
Park, Young-Bae ;
Kim, Hyo-Soo .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (09) :933-943
[3]
Strategies to promote donor cell survival: Combining preconditioning approach with stem cell transplantation [J].
Haider, Husnain Kh ;
Ashraf, Muhammad .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 45 (04) :554-566
[4]
Regulating the regulator:: NF-κB signaling in heart [J].
Hall, Gentzon ;
Hasday, Jeffery D. ;
Rogers, Terry B. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 41 (04) :580-591
[5]
The IκB-NF-κB signaling module:: Temporal control and selective gene activation [J].
Hoffmann, A ;
Levchenko, A ;
Scott, ML ;
Baltimore, D .
SCIENCE, 2002, 298 (5596) :1241-1245
[6]
NF-κB at the crossroads of life and death [J].
Karin, M ;
Lin, A .
NATURE IMMUNOLOGY, 2002, 3 (03) :221-227
[7]
Nuclear factor-κB in cancer development and progression [J].
Karin, Michael .
NATURE, 2006, 441 (7092) :431-436
[8]
NFκB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis [J].
Kühnel, F ;
Zender, L ;
Paul, Y ;
Tietze, MK ;
Trautwein, C ;
Manns, M ;
Kubicka, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (09) :6421-6427
[9]
Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-κB-dependent pathway [J].
Li, Qianhong ;
Guo, Yiru ;
Tan, Wei ;
Ou, Qinghui ;
Wu, Wen-Jian ;
Sturza, Diana ;
Dawn, Buddhadeb ;
Hunt, Greg ;
Cui, Chuanjue ;
Bolli, Roberto .
CIRCULATION, 2007, 116 (14) :1577-1584
[10]
Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair [J].
Mirotsou, Maria ;
Zhang, Zhongyan ;
Deb, Arjun ;
Zhang, Lunan ;
Gnecchi, Massimiliano ;
Noiseux, Nicolas ;
Mu, Hui ;
Pachori, Alok ;
Dzau, Victor .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (05) :1643-1648